Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Garofalo

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Advances in Clinical Chemistry|June 23, 2026
Biomarkers in heart failureManuel Garofalo, Giorgia Panichella, Alberto Aimo
Kardiologia Polska|August 22, 2025
Cardiac resynchronization therapy improves functional status and cognition at long term follow-upMatteo Beltrami, Giuseppe Mascia, Paolo Pieragnoli, et al.
Heart Failure Reviews|August 11, 2023
Sex differences in transthyretin cardiac amyloidosisAlberto Aimo, Giorgia Panichella, Manuel Garofalo, et al.
Current Cardiology Reports|December 1, 2025
Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy: from Pathophysiology To Real World DataGiorgia Panichella, Manuel Garofalo, Maddalena Ragagnin, et al.
Clinical Cardiology|March 30, 2026
Stent Thrombosis: A Narrative Review From Pathophysiology to TherapyEmanuele Cecchi, Andrea Grasso Granchietti, Ruggero Mazzotta, et al.
Frontiers in Cardiovascular Medicine|June 28, 2023
The role of fibrosis, inflammation, and congestion biomarkers for outcome prediction in candidates to cardiac resynchronization therapy: is "response" the right answer?Matteo Beltrami, Alessandro Galluzzo, Riccardo Tappa Brocci, et al.
Frontiers in Cardiovascular Medicine|December 4, 2023
Inflammation in acute heart failureManuel Garofalo, Rossana Corso, Daniela Tomasoni, et al.
Biomedicines|May 25, 2024
Pathophysiological Link and Treatment Implication of Heart Failure and Preserved Ejection Fraction in Patients with Chronic Kidney DiseaseGiacomo Bonacchi, Valentina Alice Rossi, Manuel Garofalo, et al.
ESC Heart Failure|April 18, 2025
Early administration of SGLT2 inhibitors in hospitalized patients: A practical guidance from the current evidenceRuggero Mazzotta, Manuel Garofalo, Samuele Salvi, et al.
Journal of Clinical Medicine|April 14, 2026
The Role of Serum Biomarkers for the Differential Diagnosis and Prognostic Assessment of Myocardial Infarction with Non-Obstructive Coronary Arteries: A Narrative ReviewMatteo Orlandi, Ruggero Mazzotta, Niccolò Ciardetti, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Advances in Clinical Chemistry|June 23, 2026
Biomarkers in heart failureManuel Garofalo, Giorgia Panichella, Alberto Aimo
Kardiologia Polska|August 22, 2025
Cardiac resynchronization therapy improves functional status and cognition at long term follow-upMatteo Beltrami, Giuseppe Mascia, Paolo Pieragnoli, et al.
Heart Failure Reviews|August 11, 2023
Sex differences in transthyretin cardiac amyloidosisAlberto Aimo, Giorgia Panichella, Manuel Garofalo, et al.
Current Cardiology Reports|December 1, 2025
Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy: from Pathophysiology To Real World DataGiorgia Panichella, Manuel Garofalo, Maddalena Ragagnin, et al.
Clinical Cardiology|March 30, 2026
Stent Thrombosis: A Narrative Review From Pathophysiology to TherapyEmanuele Cecchi, Andrea Grasso Granchietti, Ruggero Mazzotta, et al.
Frontiers in Cardiovascular Medicine|June 28, 2023
The role of fibrosis, inflammation, and congestion biomarkers for outcome prediction in candidates to cardiac resynchronization therapy: is "response" the right answer?Matteo Beltrami, Alessandro Galluzzo, Riccardo Tappa Brocci, et al.
Frontiers in Cardiovascular Medicine|December 4, 2023
Inflammation in acute heart failureManuel Garofalo, Rossana Corso, Daniela Tomasoni, et al.
Biomedicines|May 25, 2024
Pathophysiological Link and Treatment Implication of Heart Failure and Preserved Ejection Fraction in Patients with Chronic Kidney DiseaseGiacomo Bonacchi, Valentina Alice Rossi, Manuel Garofalo, et al.
ESC Heart Failure|April 18, 2025
Early administration of SGLT2 inhibitors in hospitalized patients: A practical guidance from the current evidenceRuggero Mazzotta, Manuel Garofalo, Samuele Salvi, et al.
Journal of Clinical Medicine|April 14, 2026
The Role of Serum Biomarkers for the Differential Diagnosis and Prognostic Assessment of Myocardial Infarction with Non-Obstructive Coronary Arteries: A Narrative ReviewMatteo Orlandi, Ruggero Mazzotta, Niccolò Ciardetti, et al.
Pageof 3